Aβ aggregation inhibitory activities of coumarin triazolyl and phenoxyphenyl triazolyl derivatives.
| ||||
|---|---|---|---|---|
| Compound | R1 | X | R2 | IC50 (μM) ±SD |
| CA1 |
|
–NH– |
|
a |
| CA2 |
|
–NH– |
|
a |
| CA3 |
|
–NH– |
|
11.58 ± 1.26 |
| CA4 |
|
–NH– |
|
a |
| CA5 |
|
–NH– |
|
a |
| CE1 |
|
–O– |
|
a |
| CE2 |
|
–O– |
|
a |
| CE3 |
|
–O– |
|
17.66 ± 5.12 |
| CE4 |
|
–O– |
|
a |
| CE5 |
|
–O– |
|
0.008 ± 5.91 |
| PA1 |
|
–NH– |
|
a |
| PA2 |
|
–NH– |
|
a |
| PA3 |
|
–NH– |
|
69.20 ± 0.99 |
| PA4 |
|
–NH– |
|
1.15 ± 1.24 |
| PA5 |
|
–NH– |
|
0.04 ± 1.61 |
| PE1 |
|
–O– |
|
4.73 ± 2.53 |
| PE2 |
|
–O– |
|
a |
| PE3 |
|
–O– |
|
36.66 ± 0.89 |
| PE4 |
|
–O– |
|
0.003 ± 0.66 |
| PE5 |
|
–O– |
|
14.13 ± 6.11 |
| Curcumin | 20.34 ± 1.87 | |||
Exhibiting inhibitory activity below 50%.